Johnson & Johnson Recalls Topomax

Attention Topomax users: there is a recall!

April 14, 2011 — Drugmaker Johnson & Johnson has issued a voluntary recall of 57,000 bottles of its Topamax epilepsy and migraine drug due to complaints of an “uncharacteristic odor” associated with the tablets.

For more information click This entry was posted in Chapter News on by .